Video

GLP-1 Receptor Agonists in Your Toolkit

Author and Disclosure Information

 

References

Davida F. Kruger explains the use of short- and long-acting GLP-1 receptor agonists in the management of diabetes.

This video provides three takeaways in less than three minutes from the presentation the 2015 MEDS conference, entitled “Incorporating GLP-1 Receptor Agonists Into Your Diabetes Toolkit: Improving Adherence and Patient Outcomes” co-presented by Holly Jodon, MPAS, PA-C, DFAAPA and supported by Creative Educational Concepts, Inc. and an independent educational grant from AstraZeneca.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

High-calorie American Diet Causes Insulin Resistance Within Days
Clinician Reviews
EASD: High A1C Linked to Elevated Dementia Risk in Patients With T2DM
Clinician Reviews
Prediabetes and Metabolic Syndrome: Current Trend
Clinician Reviews
Liraglutide/metformin Targets Glycemic Goal in Type 2 Diabetes
Clinician Reviews
Long-acting Basal Insulin Controls A1C as Well as Glargine
Clinician Reviews
When Stepping up Type 2 Treatment, GLP-1 Agonists Have the Edge
Clinician Reviews
Lipid-lowering Benefits of Alirocumab Extend to Patients With High-risk Diabetes
Clinician Reviews
Metformin-induced B12 Deficiency Linked to Diabetic Neuropathy
Clinician Reviews
Monthly Incretin-based Therapy Shows Promise in Type 2 Diabetes
Clinician Reviews
Progress in Treating Diabetic Foot Osteomyelitis
Clinician Reviews